EFPIA - NEWSLETTER

EFPIA Newsletter 07 April 2022

Shortening the WAIT - Patient Access to Medicines in Europe

Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing.

Published today, the most comprehensive EFPIA WAIT Indicator Survey to date found that the average time to reimbursement for innovative treatments across EU and European Economic Area (EEA) countries continues to be as long as 511 days. Patients in Germany wait around 133 days to access new medicines compared to patients in Romania that endure a wait of more than 899 days.

New EFPIA report on the cost of pharmaceuticals

07 April 2022 Are medicines affordable for health systems? The myths, the facts and the way forward

Pharmaceutical expenditure has been stable as a share of total healthcare expenditure in all European countries included...

Data contribution initiative

04 April 2022 Industry Pioneers the Contribution of Substance Data to decrease animal testing

A new initiative will make available previously unpublished data on chemicals tested to develop medicines.

World Health Day

Rising temperatures and sea levels, increasing CO2 levels, extreme weather affect people’s health. Find out more about what the pharmaceutical industry is doing to tackle climate change and build a #HealthierTomorrow

What we are reading

AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals... 04 April 2022 (AMR Action Fund)

The COVID-19 Pandemic Is Bad. Could it Have Been Even Worse? 25 March 2022 (Think Global Health)

Finance, culture, talent: why Europe struggles to commercialise its biotech expertise 21 March 2022 (Financial Times)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶